Using prostate cancer and fibroblast cells, they measured the initial DNA damage, primarily DNA DSBs, and examined the repair kinetics by detecting γH2A.X or 53BP1 using immunofluorescence. This evidence concerns the gene TP53BP1 and prostate carcinoma.